相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma
Stine Dam Henriksen et al.
CLINICAL EPIGENETICS (2016)
Hospital of diagnosis and likelihood of surgical treatment for pancreatic cancer
M. J. A. M. Bakens et al.
BRITISH JOURNAL OF SURGERY (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer A Literature Review
Stine Dam Henriksen et al.
PANCREAS (2015)
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens
Brian B. Haab et al.
PLOS ONE (2015)
Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas
Arpad V. Patai et al.
PLOS ONE (2015)
Correcting for Optimistic Prediction in Small Data Sets
Gordon C. S. Smith et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Prevalence of venous thromboembolism at diagnosis of upper gastrointestinal cancer
A. C. Larsen et al.
BRITISH JOURNAL OF SURGERY (2014)
IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer
Lucia Perez-Carbonell et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Hypermethylation of HIC1 Promoter and Aberrant Expression of HIC1/SIRT1 Might Contribute to the Carcinogenesis of Pancreatic Cancer
Gang Zhao et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
Werner Hartwig et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Current concepts and novel targets in advanced pancreatic cancer
Patrick Michl et al.
GUT (2013)
Methylated Tissue Factor Pathway Inhibitor 2 (TFP12) DNA in Serum Is a Biomarker of Metastatic Melanoma
Cristiana Lo Nigro et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Kruppel-Like Factor 10 Expression as a Prognostic Indicator for Pancreatic Adenocarcinoma
Vincent H. S. Chang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol
Inge Sokilde Pedersen et al.
BMC MOLECULAR BIOLOGY (2012)
Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer
M. Li et al.
MEDICAL ONCOLOGY (2012)
PRELIMINARY STUDY ANALYZING THE METHYLATED GENES IN THE PLASMA OF PATIENTS WITH PANCREATIC CANCER
J. W. Park et al.
SCANDINAVIAN JOURNAL OF SURGERY (2012)
Epigenomics in cancer management
Fabricio Costa
Cancer Management and Research (2012)
Detection of TFPI2 methylation in the serum of colorectal cancer patients
Kenji Hibi et al.
CANCER LETTERS (2011)
Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis
Yannick Delpu et al.
CURRENT GENOMICS (2011)
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review
Umashankar K. Ballehaninna et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2011)
Epigenetic tools in potential anticancer therapy
Katarina Sebova et al.
ANTI-CANCER DRUGS (2010)
Epigenetic biomarkers for human cancer: The time is now
Sonia Mulero-Navarro et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
The sunset of somatic genetics and the dawn of epigenetics: a new frontier in pancreatic cancer research
Gwen Lomberk et al.
CURRENT OPINION IN GASTROENTEROLOGY (2008)
CpG island methylation profile of pancreatic intraepithelial neoplasia
Norihiro Sato et al.
MODERN PATHOLOGY (2008)
K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients - In relation to cigarette smoking
Li Jiao et al.
PANCREAS (2007)
Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population
JE Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)